Mary Bernadette Munn MD
Maternal & Fetal Medicine/High Risk
Professor, Obstetrics & Gynecology, University of South Alabama SOM
Join to View Full Profile
1601 Center StMobile, AL 36604
Phone+1 251-415-1496
Fax+1 251-415-1450
Dr. Munn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama BirminghamFellowship, 1996 - 1998
USA HealthResidency, Obstetrics and Gynecology, 1992 - 1996
Tulane University School of MedicineClass of 1992
Certifications & Licensure
AL State Medical License 1994 - 2025
TX State Medical License 2003 - 2025
LA State Medical License 1993 - 1994
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 1 citationsRandomized trial of fundal height vs point-of-care ultrasound during routine antenatal visits.Chasey Omere, Daphne Arena Goncharov, Claudia Pedroza, Mauricio La Rosa, Mary Munn
American Journal of Obstetrics & Gynecology MFM. 2022-03-01 - Quality Improvement Initiative to Reduce Time from Regional Anesthesia Placement to Delivery for Cesarean Delivery.Mauricio La Rosa, Chasey Omere, Camille M. Webb, Brett Goldman, Rachel Laird
American Journal of Perinatology. 2020-02-01 - 12 citationsEffects of medication intake in early pregnancy on the fetal fraction of cell-free DNA testingMaggie J. Kuhlmann-Capek, Giuseppe Chiossi, Prapti Singh, Luis Monsivais, Violetta Lozovyy
Prenatal Diagnosis. 2019-04-01
Press Mentions
FDA Panel Backs Removal of Unproven Pregnancy DrugOctober 20th, 2022- FDA Panel Backs Removal of Unproven Pregnancy DrugOctober 19th, 2022
- FDA Panel Wants to Remove Drug Meant to Prevent Premature Births – NBC Los AngelesOctober 19th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
